TECTONIC THERAPEUTIC
Tectonic is a privately held biotechnology company that aims to transform the discovery of novel GPCR-targeted drugs and unlock the therapeutic utility the most challenging receptors in the class. Tectonic’s founders are at the forefront of scientific research in biochemistry and molecular pharmacology with an extensive track record of entrepreneurial achievement.
TECTONIC THERAPEUTIC
Industry:
Biotechnology
Founded:
2020-02-01
Address:
Allston, Massachusetts, United States
Country:
United States
Website Url:
http://www.tectonictx.com
Total Employee:
11+
Status:
Active
Total Funding:
80 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Apache
Similar Organizations
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Vera Therapeutics
Vera Therapeutics is a biotechnology company developing innovative biologic therapeutics with transformative clinical potential.
Current Advisors List
Current Employees Featured
Founder
Investors List
Vida Ventures
Vida Ventures investment in Series A - Tectonic Therapeutic
Timothy A. Springer
Timothy A. Springer investment in Series A - Tectonic Therapeutic
Polaris Partners
Polaris Partners investment in Series A - Tectonic Therapeutic
EcoR1 Capital
EcoR1 Capital investment in Series A - Tectonic Therapeutic
Polaris Partners
Polaris Partners investment in Seed Round - Tectonic Therapeutic
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-22 | Tectonic Therapeutic Appoints Marcella Ruddy, MD as Chief Medical Officer |
Official Site Inspections
http://www.tectonictx.com
- Host name: host.nhwebdesign.com
- IP address: 107.20.173.90
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Tectonic Therapeutic"
Tectonic Therapeutic - Homepage - Tectonic Therapeutic
Interested applicants may write to [email protected] with attached cover letter and CV in PDF format. Please include the job reference ID in the subject line. We are an equal opportunity …See details»
Tectonic Therapeutic, Inc. | LinkedIn
Tectonic Therapeutic, Inc. Biotechnology Watertown, Massachusetts 3,903 followers Transforming the discovery of novel GPCR-targeted therapiesSee details»
AVROBIO and Tectonic Therapeutic Announce Merger
About the Proposed Transaction: Financials, Management and Organization Upon completion of the Merger, pre-Merger AVROBIO shareholders are expected to own approximately 22.3% of …See details»
Tectonic Therapeutic Initiates Phase 1 Study for TX45 in Group 2 ...
The World Health Organization has defined 5 groups of pulmonary hypertension (PH). Tectonic is focused ... Learn more at www.tectonictx.com and follow us @TectonicTx. Tectonic …See details»
Tectonic Therapeutic to Host KOL Event on the Unmet Need in …
5 days ago The World Health Organization has defined five groups of pulmonary hypertension (“PH”). Tectonic is focused on the Group 2 subtype, a condition that develops due to left-sided …See details»
Tectonic Therapeutic - Crunchbase Company Profile & Funding
Tectonic Therapeutic may be growing as it successfully raised USD 80 million in financing in April 2021, which is a significant financial milestone indicating investor confidence and the potential …See details»
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA …
Nov 11, 2024 The World Health Organization has defined 5 groups of pulmonary hypertension (“PH”). Tectonic is focused on the Group 2 subtype, a condition that develops due to left-sided …See details»
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
Oct 22, 2024 The World Health Organization has defined 5 groups of PH. Tectonic is focused on the Group 2 subtype, a condition that develops due to left-sided heart disease, specifically …See details»
Tectonic Therapeutic Announces Closing of Merger with AVROBIO …
Jun 20, 2024 For more information, please visit www.tectonictx.com and follow @TectonicTx on X (formerly Twitter) and LinkedIn. Forward-Looking Statements.See details»
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
Oct 22, 2024 For more information, please visit www.tectonictx.com and follow @TectonicTx on X (formerly Twitter) and LinkedIn. Contacts: Investor: Dan Ferry LifeSci Advisors …See details»
Tectonic Therapeutic Announces Positive Phase 1a Results in AHA …
Nov 11, 2024 Phase 1a results support further development of TX000045 (“TX45”) for Group 2 Pulmonary Hypertension in HFpEF (“PH-HFpEF”), based on favorable pharmacokinetic profile …See details»
Tectonic Therapeu .c Strengthens Leadership Team
Jul 19, 2022 www.tectonictx.com, or follow us on LinkedIn. ### CONTACTS: Investor Contact: Chris/an Cor/s, PhD Tectonic Therapeu/c ccor/[email protected] (781) 327-2606 Media …See details»
Tectonic Therapeutic Announces Start of First Clinical Program for …
Nov 28, 2023 Investor: Christian Cortis, PhD Tectonic Therapeutic [email protected] (781) 327-2606 Media: Karen Sharma MacDougall [email protected] (781) 235-3060 Site …See details»
Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
Oct 22, 2024 American Heart Association (AHA) poster to be presented on November 16, 2024WATERTOWN, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. …See details»
Piper Sandler 36th Annual Healthcare Conference
4 days ago The Investor Relations website contains information about Tectonic Therapeutic's business for stockholders, potential investors, and financial analysts.See details»
Tectonic Therapeutic Announces Favorable Phase 1a Safety, …
Sep 19, 2024 Tectonic Therapeutic. TX45 was well-tolerated with no observed immunogenicity, and demonstrated a favorable PK/PD relationship which was used to identify doses for the …See details»
Tectonic Therapeutic Launches with $80 Million Series A Financing …
Apr 15, 2021 For more information, please visit www.tectonictx.com, or follow us on LinkedIn. CONTACTS: Investor Contact: Christian Cortis, Ph.D. Tectonic Therapeutic …See details»
TX-000045 - Drug Targets, Indications, Patents - Synapse - Patsnap
Dec 3, 2023 For more information, please visit www.tectonictx.com and follow on LinkedIn. ... About Group 2 Pulmonary Hypertension in HFpEF The World Health Organization has defined …See details»
Fierce Biotech names Tectonic Therapeutic 2021
Sep 27, 2021 information, please visit www.tectonictx.com, or follow us on LinkedIn. ### CONTACTS: Investor Contact: Christian Cortis, PhD Tectonic Therapeutic …See details»
Tectonic Therapeutic Announces Second Quarter 2024 Financial …
Aug 14, 2024 The decrease was primarily due to a reduction in Contract Manufacturing Organization (CMO) costs as a result of fewer batches of clinical trial supply produced during …See details»